Clinical Trial Imaging Market Size Worth $1.97 Billion By 2030: Grand View Research, Inc.

SAN FRANCISCO, May 2, 2022 /PRNewswire/ -- The global clinical trial imaging market is expected to reach USD 1.97 billion by 2030, exhibiting a CAGR of 8.7%, according to a new report by Grand View Research, Inc. Increasing research and development spending to discover new drugs and therapies to treat chronic diseases is propelling the industry growth. Images obtained from the internal examination of the body are used to determine drug activity. Clinical trial imaging provides rapid, detailed, and accurate screening. The need for clinical trial imaging is rapidly increasing in all phases of trials. Medical imaging in clinical trials is used as a primary, quantitative, and surrogate biomarker.

Key Insights & Findings from the report:

• Project and Data Management Services held the largest share in 2021 due to the growing requirement for data management and workflow for clinical trial imaging.
• Operational imaging services held a significant share in 2021 and include imaging modalities such as MRI, CT scan, Ultrasound, Optical Coherence Tomography (OCT), X-rays, and others.
• CT Scan modality held the largest share in 2021 due to its non-invasive nature and its ability to provide detailed information about the disease for enhanced treatment.
• The other application segment held the largest share in 2021. This segment includes oncology, neurology, and musculoskeletal. Market players such as ICON, Bioclinica, Navitas Life Sciences, and Paraxel International are developing their clinical trial imaging services for these applications.
• CROs held the largest share in 2021 due to increasing investments in the field of research and development, snowballing outsourcing activities by the pharmaceutical and biotechnology companies to cut down the cost and time, and patent expiration.
• North America dominated this market with the largest share in 2021 due to the increasing geriatric population, along with chronic diseases and growing demand for treatment options.

Read 111 page market research report, "Clinical Trial Imaging Market Size, Share & Trends Analysis Report By Services (Clinical Trial Design And Consultation Services, Reading And Analytical Services), By End Use, By Application, By Region, And Segment Forecasts, 2022 - 2030", published by Grand View Research.

Clinical Trial Imaging Market Growth & Trends

The clinical trial design includes selecting patient population, stratification based on biomarkers, different methods for allocation treatments, choosing efficient and reliable endpoints and validation of surrogate endpoints, calculating sample size, trial simulations, adaptive trial set-up, statistical and interim analysis, and assisting clients to deal with regulatory authorities such as EMA and FDA to discuss study design or defend study results.

Market players provide analytical testing services, pharmacokinetic, reading, and pharmacodynamics services for enhanced clinical development. IXICO offers advanced technologies for catalyzing clinical trials in neuroscience. Imaging biomarkers by the company help in measuring the safety and effectiveness of therapies used for neuro-imaging. Imaging biomarkers are effective in radiological reads. This provides the reading of MRI scans for central neuro to enhance the assessment of ongoing monitoring of drug safety and subject eligibility

Clinical Trial Imaging Market Report Highlights

Grand View Research has segmented the global clinical trial imaging market based on service, application, end-use, and region:

Clinical Trial Imaging Market - Service Outlook (Revenue, USD Million, 2018 - 2030)

• Clinical Trial Design and Consultation Services
• Reading and Analytical Services
• Operational Imaging Services
• Computed Tomography (CT) Scan
• MRI (Magnetic Resonance Imaging)
• X-Ray
• Ultrasound
• Optical Coherence Tomography (OCT)
• Others
• System and Technology Support Services
• Project and Data Management

Clinical Trial Imaging Market - Application Outlook (Revenue, USD Million, 2018 - 2030)

• NASH
• CKD
• Diabetes
• Cardiovascular Diseases
• Musculoskeletal
• Oncology
• Gastroenterology
• Pediatrics
• Others

Clinical Trial Imaging Market End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Biotechnology and Pharmaceutical companies
• Medical Devices Manufacturers
• Academic and Government Research Institutes
• Contract Research Organizations (CROs)
• Others

Clinical Trial Imaging Market - Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Italy
• Spain
• Asia Pacific
• India
• China
• Japan
• Thailand
• South Korea
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

 List of Key Players in the Clinical Trial Imaging Market

• IXICO plc
• Navitas Life Sciences
• Resonance Health
• ProScan Imaging
• Radiant Sage LLC
• Medpace
• Biomedical Systems Corp.
• Cardiovascular Imaging Technologies
• Intrinsic Imaging

Check out more related studies published by Grand View Research:

• Clinical Trial Supplies Market - The global clinical trial supplies market size is expected to reach USD 3.40 billion by 2030, registering a CAGR of 6.4% during the forecast period, according to a new report by Grand View Research, Inc. This growth can be attributed to the increasing volume of clinical trial studies coupled with the growing complexity of conducting these trials. The COVID-19 pandemic has created opportunities for local manufacturers. To enhance their foothold in the market, key companies are adopting various plans and policies to gain a higher market share. The clinical trial and pharmaceutical industry is anticipated to witness steady growth, which, in turn, will increase the demand for clinical trial supplies, thereby driving the market growth.
• Clinical Trial Equipment & Ancillary Solutions Market - The global clinical trial equipment & ancillary solutions market is expected to reach USD 5.09 billion by 2030, expanding at a CAGR of 8.1% over the forecast period according to a new report by Grand View Research, Inc. The growing pharmaceutical and medical sectors, globalization of clinical trials, and rising R&D expenditure are the factors driving the market. However, The COVID-19 pandemic has affected the global market, which resulted in slowing down the supply chain of the equipment & ancillary supplies. The COVID-19 pandemic has caused major changes in the clinical trial environment. Hundreds of experiments that were in progress before the pandemic was halted due to COVID-19 globally.
• Clinical Trials Support Services Market - The global clinical trials support services market is expected to reach USD 37.1 billion by 2030, registering a CAGR of 7.5% from 2022 to 2030, according to a new report by Grand View Research, Inc. Increasing the number of CROs offering clinical trial support services, and huge investment in research & development by the pharmaceutical and biopharmaceutical companies are the key factors driving the market growth. The industry felt the impact of the COVID-19 pandemic. The pandemic disrupted the supply chain to a severe extent in 2020. However, it also revealed ways to grow, either through M&A or through the adoption of digital technologies in clinical research.

Browse through Grand View Research's  Medical Devices Industry Research Reports.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com   
Web: https://www.grandviewresearch.com    
Grand View Compass | Grand View Pipeline    
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg